investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of a Genomic Expression Signature Associated with Chemoresistance
Douglas C Marchion
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Douglas C Marchion
Moffitt Cancer Center
Tampa, United States
Related projects
Kent Hunter
Genetic Modifiers of Initiation and Progression of Mammary Cancer
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Akhilesh Pandey
Personalized Therapy of Hormone Refractory Breast Cancer
Breast
William C Hahn
Regulation and function of IKKe in breast cancer initiation and maintenance
Breast
Pathology
Mala Pande
Susceptibility Markers for a Breast-Colon Cancer Phenotype
Breast
Brian D Dynlacht
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
Breast
Khandan Keyomarsi
Targeting the cell cycle in triple negative breast cancer
Breast
Dipak Panigrahy
Control of Cancer and Metastasis by Endothelial-Derived Epoxyeicosatrienoic Acids
Breast